A widely used class of diabetes medications appears to be associated with an increased risk for fractures, according to a new article.

After adjusting for other risk factors, individuals who were currently taking rosiglitazone and pioglitazone had approximately double or triple the odds of hip and other non-spine fractures than those who did not take these drugs.